EarliPoint Health receives expanded FDA clearance for autism assessment in children up to age 8.

Read Release →

The Difference Between a Language Delay and a Social Delay

On This Page

Every parent who has watched another child talk in full sentences while their own toddler stays quiet has felt that particular anxiety. The answer depends less on how many words a child is using and more on what they are doing when they are not using words.

That distinction is often missed, but it matters. A language delay affects how a child understands and uses words. A social delay affects how a child engages with others—how they share attention, respond to people, use eye contact or gestures, and participate in back-and-forth interaction.

A child with a language delay is often still trying to connect—pointing, bringing things to show you, responding to their name, or using eye contact—even if words are limited. A child with a social delay may have more difficulty with those early social behaviors, even if they have some words.

What a Language Delay Looks Like

A child with a speech-only delay is still communicating. They are simply doing it without words. According to the CDC’s milestones, most children wave goodbye by 12 months and point to show interest by 18 months. Nodding or shaking the head to mean yes and no typically emerges closer to 24 months. These are not incidental behaviors. They are the earliest form of intentional communication, and children with language delays typically use them.

A toddler who cannot yet say “more” but pushes an empty bowl toward you, makes eye contact, and waits, is telling you something. A child who points to a dog across the street and then looks back at you to share excitement is demonstrating joint attention, the ability to direct another person’s focus toward something of mutual interest. That is a social skill, and its presence is a meaningful sign.

What a Social Delay Looks Like

A social delay involves a different pattern. What is absent or reduced is the impulse to use communication as a bridge to other people. A child with a social delay may not respond to their name, rarely point to share attention, and not look to a parent’s face for reassurance or reaction.

Research describes reduced social motivation to connect as a core feature of autism spectrum disorder, specifically distinct from other types of social delay. When that drive to reach toward others is diminished, language development is often affected too, not as a cause but as a consequence.

The Gesture Question

The single clearest early signal parents can watch for involves gestures. Research by Goldin-Meadow and colleagues has shown that gesture use at 12 to 14 months predicts vocabulary size significantly later in development: children who point, wave, and show objects early tend to have stronger language outcomes down the road. A child who is not yet talking but who waves, nods, and points is showing a fundamentally intact communicative foundation. The absence of gestures and shared moments of attention are among the key early signs that warrant a closer developmental look.

When to Seek an Evaluation

The American Academy of Pediatrics recommends screening all children for autism at 18 and 24 months. Early intervention, delivered before age 3 during a period of heightened neuroplasticity, produces the strongest outcomes, though meaningful progress remains possible with support at later ages as well.

The Bottom Line

A child who is quiet but still reaching toward you, pointing at things, and making eye contact to check your reaction is communicating. A quiet child who is not doing those things needs a closer look. The difference between a language delay and a social delay is not always visible in a single moment, but it is observable and worth acting on early.

Cheryl Tierney, MD, MPH

Chief Medical Officer

Developmental pediatrician, public health advocate, and Chief Medical Officer at EarliPoint Health. Cheryl blends scientific curiosity with real-world passion — as a physician, professor, and mom, she’s committed to turning early autism research into better care and support for families.

Cheryl Tierney, MD, MPH

Chief Medical Officer

Cheryl serves as EarliPoint’s Chief Medical Officer, helping advance early autism research into more accessible care and support for families.

See how EarliPoint fits seamlessly into your clinical workflow.

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder